Pacira Appoints CMO
This article was originally published in Scrip
Parsippany, New Jersey-based Pacira Pharmaceuticals, Inc. has named Dr. James B. Jones senior vice-president and chief medical officer. Most recently Jones was vice-president at The Medicines Company. At Pacira, he will be primarily responsible for overseeing and guiding the company's clinical research and development efforts for the expanded uses of Exparel (bupivacaine liposome injectable suspension) and the DepoFoam pipeline of products. Jones replaces former CMO Dr. Gary Patou, who will remain with the company as a clinical consultant.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.